Home/Pipeline/Teriparatide Injection

Teriparatide Injection

Osteoporosis

Approved/CommercialMarketed

Key Facts

Indication
Osteoporosis
Phase
Approved/Commercial
Status
Marketed
Company

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals is a vertically integrated biopharmaceutical company with a core mission to develop and deliver high-quality, complex generic and proprietary injectable, inhalation, and intranasal medications. The company has established a strong commercial footprint with products like BAQSIMI®, the leading prescribed glucagon in the U.S., and has been recognized by the FDA for its efforts in alleviating critical drug shortages. Its strategic direction leverages proprietary technological platforms to advance a pipeline of biosimilars and innovative drug delivery systems, aiming to provide accessible treatments across therapeutic areas such as diabetes, respiratory diseases, and anemia.

View full company profile

Other Osteoporosis Drugs

DrugCompanyPhase
DenosumabBioconPhase 3
RT-102Rani TherapeuticsPhase 1
EBP05Entera BioPreclinical